As PayPal renegotiates terms with unprofitable unbranded checkout (Braintree) customers, revenue growth is muted. Under the surface, demand for the company's products is strong. PayPal looks to be good value as it improves profitability, grows active accounts and engagement, and aggressively buys back shares. In the long term, new products can accelerate growth, with Debit Card TPV growing 64% y-o-y, Venmo TPV growing 50%, and BNPL volume up 20%.

MP Materials is the only non-China fully integrated mine-to-magnet rare earth producer, uniquely positioned for U.S. supply chain security and margin capture. Strategic GM offtake agreement, U.S. policy incentives, and a critical rare earth supply gap support robust long-term demand and margin expansion. Despite a 40% stock pullback after halting China-bound shipments, I see this as a buying opportunity given MP's downstream shift and undervalued premium positioning.

Arista and HPE expand AI-focused networking portfolios. See how earnings trends, valuations, and market move stack up for these industry rivals.

NEW YORK , May 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ: BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline.

SWTX wins CHMP backing for mirdametinib in NF1-PN. EU nod is expected in the third quarter of 2025.

Trump Media & Technology Group Corp (NASDAQ:DJT), the company behind Truth Social and controlled by the Trump family, is seeking to raise $3 billion to invest in cryptocurrencies such as bitcoin, the Financial Times reported on Monday. The company plans to raise $2 billion through an equity offering and another $1 billion via a convertible bond, the report said.

IBKR capitalizes on market volatility, with Trump's tariff announcement sparking surges in trading activity, DARTs, and new account growth. Q1 2025 results exceeded expectations: adjusted net revenues up 15% YoY, pretax margin at 73%, and strong operating leverage. April metrics highlight momentum: 3.7 million accounts (+32% YoY), 3.8 million DARTs (+63% YoY), and $133 billion in client credit balances.

AGNC Investment's proactive hedging, stable Agency MBS income and 16.29% dividend yield give it an edge over Starwood Property.

NIO and Tesla face challenges, but one seems better placed now. We break down what drives each and which EV stock deserves your attention today.

United Airlines reaches a tentative deal with flight attendants, offering top-tier pay, bonuses and scheduling gains for 28,000 crew over five years.

Merck stock lags industry as Keytruda dependency, Gardasil woes in China, and tariff risks cloud outlook despite pipeline strength and new launches.

Transaction in Own Shares 26 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 26 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 26/05/2025 399,111 €29.3700 €29.1950 €29.2828 XAMS EUR 26/05/2025 155,116 €29.3700 €29.2000 €29.2831 CBOE DXE EUR 26/05/2025 60,773 €29.3700 €29.2000 €29.2902 TQEX EUR These share purchases form part …

Wall Street analysts are holding a slightly bearish outlook on Lucid's (NASDAQ: LCID) stock over the next year as the equity continues to experience increased volatility.

Shares of Amazon.com Inc. (NASDAQ: AMZN) slipped by 0.3% over the past five trading sessions, briefly muting a rally that's seen the stock gain 11.58% over the past month.

Shares of Palantir Technologies Inc. (NASDAQ:PLTR) were mostly flat over the past five trading sessions, falling by 0.10%.

Sprouts Farmers, United Natural, Beyond Meat and General Mills are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

DY gains from fiber-to-the-home programs and hyperscaler projects, offsetting macro and tariff headwinds with strong long-term growth visibility.

Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its blockbuster drugs, Keytruda and Gardasil.

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: New York, N.Y., May 26, 2025.

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.